大环内酯类抗生素序贯疗法治疗小儿支原体肺炎的临床疗效及安全性分析  

Clinical efficacy and safety analysis of sequential therapy of macrolide antibiotics in the treatment of children with mycoplasma pneumonia

作　　者：廖晓梅[1] Liao Xiaomei(The First People's Hospital of Chenzhou City,Hunan Chenzhou 423000)

机构地区：[1]郴州市第一人民医院,湖南郴州423000

出　　处：《中国社区医师》2020年第15期35-36,共2页Chinese Community Doctors

摘　　要：目的:探讨大环内酯类抗生素序贯疗法治疗小儿支原体肺炎的临床效果。方法:2017年5月-2019年5月收治小儿支原体肺炎患儿100例,随机分为两组,各50例。对照组采用阿奇霉素治疗;观察组采用大环内酯类抗生素序贯治疗。比较两组治疗效果。结果:观察组治疗总有效率、临床症状消失时间及不良反应发生率均优于对照组,差异有统计学意义(P<0.05)。结论:大环内酯类抗生素序贯疗法治疗支原体肺炎,效果显著。Objective:To investigate the clinical effect of sequential therapy of macrolide antibiotics in the treatment of children with mycoplasma pneumonia.Methods:From May 2017 to May 2019,100 children with mycoplasma pneumonia were enrolled,they were randomly divided into two groups with 50 cases in each group.The control group was treated with azithromycin.The observation group was treated with sequential therapy of macrolide antibiotics.The therapeutic effects between the two groups was compared.Results:The total effective rate of treatment,the disappearance time of clinical symptoms and the incidence of adverse reactions in observation group were better than in the control group,the differences were statistically significant(P<0.05).Conclusion:Sequential therapy of macrolide antibiotics is effective in treating mycoplasma pneumonia.

关 键 词：大环内酯类抗生素 序贯治疗 小儿支原体肺炎 安全性 

分 类 号：R725.6[医药卫生—儿科]